Author:
HrŽenjak Terezija M,PopoviĆ Maja,TiŠka-rudman Ljerka
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Oncology,General Medicine,Pathology and Forensic Medicine
Reference30 articles.
1. Brommer EJP,Emeis JJ,Verheijen JH,et al: Progress in Clinical Fibrinolysis. In: 7 Recent Advances in Blood Coagulation. (Eds. Poller L and Ludlam CA), Churchill Livingstone, 1997, pp. 161-182.
2. Bugge TH, Flick MJ, Danton MJ, et al: Urokinase-type plasminogen activator is effective in fibrin clearance in the absence of its receptor or tissue-type plasminogen activator. Proc Natl Acad Sci USA 93:5899–5904, 1996.
3. Cooper DL, Sandler AB, Wilson LD, et al: Disseminated Intravascular Coagulation and Excessive Fibrinolysis in a Patient with Metastatic Prostate Cancer. Cancer 70:656–658, 1992.
4. Driscoll J and Goldberg AL: The proteasome (multicatalytic protease) is a component of the 1500 kDa proteolytic complex which degrades ubiquitin-conjugated proteins. J Biol Chem 265:4789–4792, 1990.
5. Gandolfo GM, Conti L and Vercillo M: Fibrinolysis Components as Prognostic Markers in Breast Cancer and Colorectal Carcinoma. Anticancer Res 16:2155–2160, 1996.
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献